# A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

> **NCT07161544** · PHASE1,PHASE2 · RECRUITING · sponsor: **AAVantgarde Bio Srl** · enrollment: 75 (estimated)

## Conditions studied

- Stargardt Disease

## Interventions

- **BIOLOGICAL:** AAVB-039

## Key facts

- **NCT ID:** NCT07161544
- **Lead sponsor:** AAVantgarde Bio Srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-29
- **Primary completion:** 2032-07
- **Final completion:** 2032-07
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161544, "A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07161544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*